Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Douhan J 3rd"'
Autor:
Schnute ME; Medicine Design and Inflammation and Immunology Research, Pfizer, Cambridge, Massachusetts 02139, United States., Benoit SE; Medicine Design and Inflammation and Immunology Research, Pfizer, Cambridge, Massachusetts 02139, United States., Buchler IP; Medicine Design and Inflammation and Immunology Research, Pfizer, Cambridge, Massachusetts 02139, United States., Caspers N; Medicine Design, Pfizer, Groton, Connecticut 06340, United States., Grapperhaus ML; Medicinal Chemistry and Inflammation and Immunology Research, Pfizer, St. Louis, Missouri 63017, United States., Han S; Medicine Design, Pfizer, Groton, Connecticut 06340, United States., Hotchandani R; Medicine Design and Inflammation and Immunology Research, Pfizer, Cambridge, Massachusetts 02139, United States., Huang N; Medicine Design and Inflammation and Immunology Research, Pfizer, Cambridge, Massachusetts 02139, United States., Hughes RO; Medicine Design and Inflammation and Immunology Research, Pfizer, Cambridge, Massachusetts 02139, United States., Juba BM; Medicine Design and Inflammation and Immunology Research, Pfizer, Cambridge, Massachusetts 02139, United States., Kim KH; Medicine Design and Inflammation and Immunology Research, Pfizer, Cambridge, Massachusetts 02139, United States., Liu E; Medicine Design and Inflammation and Immunology Research, Pfizer, Cambridge, Massachusetts 02139, United States., McCarthy E; Medicine Design and Inflammation and Immunology Research, Pfizer, Cambridge, Massachusetts 02139, United States., Messing D; Medicine Design and Inflammation and Immunology Research, Pfizer, Cambridge, Massachusetts 02139, United States., Miyashiro JS; Medicine Design and Inflammation and Immunology Research, Pfizer, Cambridge, Massachusetts 02139, United States., Mohan S; Medicine Design and Inflammation and Immunology Research, Pfizer, Cambridge, Massachusetts 02139, United States., O'Connell TN; Medicine Design, Pfizer, Groton, Connecticut 06340, United States., Ohren JF; Medicine Design, Pfizer, Groton, Connecticut 06340, United States., Parikh MD; Medicine Design, Pfizer, Groton, Connecticut 06340, United States., Schmidt M; Medicinal Chemistry and Inflammation and Immunology Research, Pfizer, St. Louis, Missouri 63017, United States., Selness SR; Medicinal Chemistry and Inflammation and Immunology Research, Pfizer, St. Louis, Missouri 63017, United States., Springer JR; Medicine Design and Inflammation and Immunology Research, Pfizer, Cambridge, Massachusetts 02139, United States., Thanabal V; Medicine Design, Pfizer, Groton, Connecticut 06340, United States., Trujillo JI; Medicine Design, Pfizer, Groton, Connecticut 06340, United States., Walker DP; Medicinal Chemistry and Inflammation and Immunology Research, Pfizer, St. Louis, Missouri 63017, United States., Wan ZK; Medicine Design and Inflammation and Immunology Research, Pfizer, Cambridge, Massachusetts 02139, United States., Withka JM; Medicine Design, Pfizer, Groton, Connecticut 06340, United States., Wittwer AJ; Medicinal Chemistry and Inflammation and Immunology Research, Pfizer, St. Louis, Missouri 63017, United States., Wood NL; Medicine Design and Inflammation and Immunology Research, Pfizer, Cambridge, Massachusetts 02139, United States., Xing L; Medicine Design and Inflammation and Immunology Research, Pfizer, Cambridge, Massachusetts 02139, United States., Zapf CW; Medicine Design and Inflammation and Immunology Research, Pfizer, Cambridge, Massachusetts 02139, United States., Douhan J 3rd; Medicine Design and Inflammation and Immunology Research, Pfizer, Cambridge, Massachusetts 02139, United States.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2018 Dec 03; Vol. 10 (1), pp. 80-85. Date of Electronic Publication: 2018 Dec 03 (Print Publication: 2019).
Autor:
Benson MJ; Biotherapeutics Immunoscience, Pfizer Inc., Cambridge, MA 02140; Micah.Benson@Pfizer.com., Rodriguez V; Biotherapeutics Immunoscience, Pfizer Inc., Cambridge, MA 02140;, von Schack D; Biotherapeutics Clinical Research and Development, Pfizer Inc., Cambridge, MA 02140;, Keegan S; Biotherapeutics Immunoscience, Pfizer Inc., Cambridge, MA 02140;, Cook TA; Biotherapeutics Immunoscience, Pfizer Inc., Cambridge, MA 02140;, Edmonds J; Biotherapeutics Immunoscience, Pfizer Inc., Cambridge, MA 02140;, Benoit S; Biotherapeutics Immunoscience, Pfizer Inc., Cambridge, MA 02140;, Seth N; Biotherapeutics Immunoscience, Pfizer Inc., Cambridge, MA 02140;, Du S; Biotherapeutics Clinical Research and Development, Pfizer Inc., Cambridge, MA 02140;, Messing D; Biotherapeutics Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc., Cambridge, MA 02140; and., Nickerson-Nutter CL; Biotherapeutics Immunoscience, Pfizer Inc., Cambridge, MA 02140;, Dunussi-Joannopoulos K; Biotherapeutics Immunoscience, Pfizer Inc., Cambridge, MA 02140;, Rankin AL; Biotherapeutics Immunoscience, Pfizer Inc., Cambridge, MA 02140;, Ruzek M; Biotherapeutics Immunoscience, Pfizer Inc., Cambridge, MA 02140;, Schnute ME; Biotherapeutics Medicinal Chemistry, Pfizer Inc., Cambridge, MA 02140., Douhan J 3rd; Biotherapeutics Immunoscience, Pfizer Inc., Cambridge, MA 02140;
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2014 Jul 01; Vol. 193 (1), pp. 185-97. Date of Electronic Publication: 2014 Jun 04.
Autor:
Rankin AL; Immunoscience, Pfizer Research, Cambridge, MA 02140;, Seth N, Keegan S, Andreyeva T, Cook TA, Edmonds J, Mathialagan N, Benson MJ, Syed J, Zhan Y, Benoit SE, Miyashiro JS, Wood N, Mohan S, Peeva E, Ramaiah SK, Messing D, Homer BL, Dunussi-Joannopoulos K, Nickerson-Nutter CL, Schnute ME, Douhan J 3rd
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2013 Nov 01; Vol. 191 (9), pp. 4540-50. Date of Electronic Publication: 2013 Sep 25.
Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis.
Autor:
Kim KH; Medicinal Chemistry, Pfizer, 200 Cambridge Park Drive, Cambridge, MA 02140, United States. khkim87@hotmail.com, Maderna A, Schnute ME, Hegen M, Mohan S, Miyashiro J, Lin L, Li E, Keegan S, Lussier J, Wrocklage C, Nickerson-Nutter CL, Wittwer AJ, Soutter H, Caspers N, Han S, Kurumbail R, Dunussi-Joannopoulos K, Douhan J 3rd, Wissner A
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2011 Nov 01; Vol. 21 (21), pp. 6258-63. Date of Electronic Publication: 2011 Sep 10.
Autor:
Douhan J 3rd; Inflammation, Wyeth Research, Cambridge, MA 02140, USA. jdouhan@wyeth.com, Miyashiro JS, Zhou X, Cole DC, Wu PW, Collins M, Dunussi-Joannopoulos K
Publikováno v:
Assay and drug development technologies [Assay Drug Dev Technol] 2007 Dec; Vol. 5 (6), pp. 751-8.
Autor:
Marusic S; Wyeth Research, Building. G, 1 Burtt Road, Andover MA 01810-5901, USA. smarusic@genetics.com, Miyashiro JS, Douhan J 3rd, Konz RF, Xuan D, Pelker JW, Ling V, Leonard JP, Jacobs KA
Publikováno v:
Neuroscience letters [Neurosci Lett] 2002 Nov 08; Vol. 332 (3), pp. 185-9.
Autor:
Zhou H; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA., Su HS, Zhang X, Douhan J 3rd, Glimcher LH
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 1997 May 15; Vol. 158 (10), pp. 4741-9.
Autor:
Douhan J 3rd; Department of Cancer Biology, Harvard School of Public Health, Boston, Massachusetts 02115, USA., Hauber I, Eibl MM, Glimcher LH
Publikováno v:
The Journal of experimental medicine [J Exp Med] 1996 Mar 01; Vol. 183 (3), pp. 1063-9.
Autor:
Douhan J 3rd; Department of Cancer Biology, Harvard School of Public Health, Boston, MA 02115, USA., Brown JA, Gleit ZL, David CS, Glimcher LH
Publikováno v:
International immunology [Int Immunol] 1996 Feb; Vol. 8 (2), pp. 255-65.
Autor:
Gonzalez-Gay MA; Department of Immunology, Mayo Clinic, Rochester, Minnesota 55905., Nabozny GH, Bull MJ, Zanelli E, Douhan J 3rd, Griffiths MM, Glimcher LH, Luthra HS, David CS
Publikováno v:
The Journal of experimental medicine [J Exp Med] 1994 Oct 01; Vol. 180 (4), pp. 1559-64.